Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience (TWST)
:TWST
Total Valuation
Twist Bioscience has a market cap or net worth of $1.90B. The enterprise value is $1.54B.
Market Cap$1.90B
Enterprise Value$1.54B
Share Statistics
Twist Bioscience has 61,148,026 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding61,148,026
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Twist Bioscience’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -23.92%.
Return on Equity (ROE)-0.16
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-23.92%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee407.99K
Profits Per Employee-84.15K
Employee Count923
Asset Turnover0.59
Inventory Turnover6.56
Valuation Ratios
The current PE Ratio of Twist Bioscience is ―. Twist Bioscience’s PEG ratio is 0.34.
PE Ratio―
PS Ratio4.47
PB Ratio3.56
Price to Fair Value3.56
Price to FCF-22.25
Price to Operating Cash Flow-30.72
PEG Ratio0.34
Income Statement
In the last 12 months, Twist Bioscience had revenue of 376.57M and earned -77.67M in profits. Earnings per share was -1.30.
Revenue376.57M
Gross Profit191.00M
Operating Income-136.26M
Pretax Income-76.95M
Net Income-77.67M
EBITDA-52.10M
Earnings Per Share (EPS)-1.30
Cash Flow
In the last 12 months, operating cash flow was -51.13M and capital expenditures -17.58M, giving a free cash flow of -68.71M billion.
Operating Cash Flow-51.13M
Free Cash Flow-68.71M
Free Cash Flow per Share-1.12
Dividends & Yields
Twist Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.19
52-Week Price Change-36.74%
50-Day Moving Average30.01
200-Day Moving Average33.64
Relative Strength Index (RSI)55.07
Average Volume (3m)1.87M
Important Dates
Twist Bioscience upcoming earnings date is Jan 30, 2026, After Close (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateJan 30, 2026
Ex-Dividend Date―
Financial Position
Twist Bioscience as a current ratio of 3.64, with Debt / Equity ratio of 15.98%
Current Ratio3.64
Quick Ratio3.33
Debt to Market Cap0.04
Net Debt to EBITDA0.79
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Twist Bioscience has paid 719.00K in taxes.
Income Tax719.00K
Effective Tax Rate<0.01
Enterprise Valuation
Twist Bioscience EV to EBITDA ratio is -11.56, with an EV/FCF ratio of -20.83.
EV to Sales4.18
EV to EBITDA-11.56
EV to Free Cash Flow-20.83
EV to Operating Cash Flow-33.08
Balance Sheet
Twist Bioscience has $250.80M in cash and marketable securities with $78.15M in debt, giving a net cash position of $172.65M billion.
Cash & Marketable Securities$250.80M
Total Debt$78.15M
Net Cash$172.65M
Net Cash Per Share$2.82
Tangible Book Value Per Share$6.31
Margins
Gross margin is 50.72%, with operating margin of -36.18%, and net profit margin of -20.63%.
Gross Margin50.72%
Operating Margin-36.18%
Pretax Margin-20.43%
Net Profit Margin-20.63%
EBITDA Margin-36.18%
EBIT Margin0.00%
Analyst Forecast
The average price target for Twist Bioscience is $38.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$38.00
Price Target Upside46.15% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast20.32%
EPS Growth Forecast63.81%